Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Revenue

Rhythm Pharmaceuticals had revenue of $32.70M in the quarter ending March 31, 2025, with 25.94% growth. This brings the company's revenue in the last twelve months to $136.86M, up 48.88% year-over-year. In the year 2024, Rhythm Pharmaceuticals had annual revenue of $130.13M with 68.06% growth.

• Revenue (ttm): $136.86M
• Revenue Growth: +48.88%
• P/S Ratio: 26.59
• Revenue / Employee: $483,615
• Employees: 283
• Market Cap: 3.75B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	130.13M	52.70M	68.06%
Dec 31, 2023	77.43M	53.79M	227.56%
Dec 31, 2022	23.64M	20.48M	649.46%
Dec 31, 2021	3.15M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.